Detailed comparison on parameters like NAV | Returns | Risk | Rating | Analysis
Risk | Very High | Very High |
Rating | 4.0 | 5.0 |
Min SIP Amount | ₹1000 | ₹100 |
Expense Ratio | 1.99 | 1.68 |
NAV | ₹31.98 | ₹208.03 |
Fund Started | 10 Jun 2020 | 20 Aug 2004 |
Fund Size | ₹1991.04 Cr | ₹15687.54 Cr |
Exit Load | Exit load of 1%, if redeemed within 3 months. | Exit load of 1% if redeemed within 1 year |
Risk
Rating
Min SIP Amount
Expense Ratio
NAV
Fund Started
Fund Size
Exit Load
1 Year | 8.21% | 18.39% |
3 Year | 16.94% | 21.91% |
5 Year | - | 22.57% |
1 Year
3 Year
5 Year
Equity | 97.78% | 83.94% |
Cash | 1.84% | 15.74% |
Equity
Cash
Top 10 Holdings |
|
|
Top 10 Holdings
Name | Assets |
---|---|
State Bank of India | 4.91% |
HDFC Bank Ltd. | 4.48% |
Vedanta Ltd. | 4.19% |
Coforge Ltd. | 3.90% |
Lloyds Metals & Energy Ltd. | 3.05% |
NTPC Green Energy Ltd. | 3.01% |
Hindustan Aeronautics Ltd. | 2.89% |
Swan Energy Ltd. | 2.52% |
REC Ltd. | 2.37% |
ICICI Bank Ltd. | 2.32% |
Name | Assets |
---|---|
ICICI Bank Ltd. | 9.18% |
HDFC Bank Ltd. | 8.88% |
Axis Bank Ltd. | 8.49% |
Maruti Suzuki India Ltd. | 4.90% |
SBI Life Insurance Company Ltd. | 4.26% |
Kotak Mahindra Bank Ltd. | 4.24% |
Cipla Ltd. | 3.96% |
Bharti Airtel Ltd. | 3.63% |
HCL Technologies Ltd. | 3.41% |
Piramal Pharma Ltd. | 3.12% |
Name | Alok Singh | Dhruv Muchhal |
Start Date | 01 Dec 2021 | 14 Sep 2023 |
Name
Start Date
Description | The scheme seeks to generate long term capital appreciation by investing predominantly in equity and equity-related securities across various market capitalisation. | The scheme seeks to generate long term capital appreciation/income by investing in equity & equity related instruments of up to 30 companies. |
Launch Date | 10 Jun 2020 | 20 Aug 2004 |
Description
Launch Date